Naganuma, Makoto http://orcid.org/0000-0002-4244-3243
Article History
Received: 17 June 2020
Accepted: 22 July 2020
First Online: 10 August 2020
Compliance with ethical standards
:
: Makoto Naganuma received commercial research funds from EA Pharma Co., Ltd. and Mochida Pharmaceutical Co., Ltd., and received lecture fees from Takeda Pharmaceutical Co., Ltd. and Pfeizer Co., Ltd.